Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate-rich protein 6B (ERICH6B) is a protein-coding gene in humans, located on chromosome 13. It is also known as FAM194B among other aliases. While the full biological function of ERICH6B is not well characterized, its gene product is part of the FAM194 family of proteins. Diseases associated with ERICH6B include ectodermal dysplasia, ectrodactyly, and macular dystrophy syndrome, as well as congenital hypotrichosis with juvenile macular dystrophy. There is currently no evidence that ERICH6B functions as a canonical therapeutic target such as a receptor, enzyme, transporter, or channel, nor are there any known drugs targeting this protein or well-established roles in specific disease pathways[1][3][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate-rich protein 6B (ERICH6B).